{
    "nctId": "NCT03738605",
    "briefTitle": "Vaginal Laser Therapy in Breast Cancer Survivors",
    "officialTitle": "Vaginal Laser Therapy for the Management of Genitourinary Syndrome of Menopause of Breast Cancer Survivors: Double-blind Randomized Placebo-controlled Trial",
    "overallStatus": "UNKNOWN",
    "conditions": "Genitourinary Syndrome of Menopause, Vaginal Atrophy, Breast Cancer, Dyspareunia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "10-centimeter Visual Analogue Scale assessing intensity of dyspareunia and dryness",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast cancer history\n* dyspareunia\n* dryness\n\nExclusion Criteria:\n\n* Active genital infection (i.e herpes, vaginitis)\n* Prolapse stage \\>=2\n* Underlying pathologies that could interfere with the protocol compliance",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}